Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.
To learn more about market share and segmentation, request the free sample pages.
Competitive Landscape of the RT PCR Test Kits Market
The competitive landscape of the RT-PCR test kits market is dynamic, characterized by a range of players including established diagnostics companies and emerging biotech firms. Key factors driving competition include technological innovation, test accuracy, speed of results, and pricing. Companies focus on developing advanced, cost-effective solutions to capture market share and address diverse diagnostic needs.
For instance, in June 2021, Abbott launched the Panbio COVID-19 antigen self-test in India, expanding its rapid diagnostics portfolio to cater to testing needs at home, work, and clinics. The panbio self-test, which has earned CE Mark approval for over-the-counter use in both adults and children, offers a minimally invasive nasal swab and delivers results in just 15 minutes without requiring additional instrumentation.
(Source: https://www.abbott.in/media-center/press-releases/abbott-launches-panbio-covid-19-antigen-self-test-in-india.html)
In November 2023, Roche introduced the LightCycler PRO System, a next-generation qPCR platform aimed at meeting evolving clinical and public health needs. This system is engineered to enhance both clinical diagnostics and research with its cutting-edge qPCR technology. The system’s advanced features leverage gold-standard technology, ensuring superior quality, precision, and reliability essential for accurate patient diagnostics and informed clinical decision-making.
(Source: https://diagnostics.roche.com/global/en/news-listing/2023/roche-launches-next-generation-qpcr-system-to-advance-clinical-needs.html)
In June 2022, Becton, Dickinson and Company, a leading global medical technology firm, announced the CE marking of its BD MAX Respiratory Viral Panel (RVP). This new molecular diagnostic test simultaneously detects SARS-CoV-2, Influenza A and B, and Respiratory Syncytial Virus (RSV) under the IVD directive 98/79/EC. Utilizing a single nasal or nasopharyngeal swab, the test provides comprehensive results to identify if a patient is infected with COVID-19, the flu, or RSV.
(Source: https://news.bd.com/2022-06-30-BD-Launches-Combination-Test-for-COVID-19,-Influenza-A-B-and-Respiratory-Syncytial-Virus)
Click any bar or cell to request the full company profile
Company
2022 (A)
2023 (A)
2024 (A)
2025 (A)
Thermo Fisher Scientific
•••
•••
•••
•••
Inc.
•••
•••
•••
•••
Bio-Rad Laboratories
•••
•••
•••
•••
Inc.
•••
•••
•••
•••
Qiagen N.V.
•••
•••
•••
•••
Takara Bio
•••
•••
•••
•••
Inc.
•••
•••
•••
•••
Agilent Technologies
•••
•••
•••
•••
Inc.
•••
•••
•••
•••
Biomérieux S.A.
•••
•••
•••
•••
Fluidigm Corporation
•••
•••
•••
•••
Danaher Corporation
•••
•••
•••
•••
Abbott Laboratories
•••
•••
•••
•••
Merck KGaA
•••
•••
•••
•••
Becton Dickinson and Company
•••
•••
•••
•••
Promega Corporation
•••
•••
•••
•••
Eppendorf AG
•••
•••
•••
•••
Analytik Jena AG
•••
•••
•••
•••
Meridian Bioscience
•••
•••
•••
•••
Inc.
•••
•••
•••
•••
Enzo Life Sciences
•••
•••
•••
•••
Inc.
•••
•••
•••
•••
Cole-Parmer Instrument Company LLC
•••
•••
•••
•••
Bioneer Corporation
•••
•••
•••
•••
Revenue data requires full access. *2nd & 3rd tier companies available on enquiry.
According to Cognitive Market Research, the global RT PCR test kits market size was USD 4126.6 million in 2024. It will expand at a compound annual growth rate (CAGR) of 6.50% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 1650.64 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.7% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 1237.98 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 949.12 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.5% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 206.33 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 82.53 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.
The real-time PCR held the highest RT PCR test kits market revenue share in 2024.
Introduction of the RT PCR Test Kits Market
RT-PCR test kits are diagnostic tools used to detect and quantify RNA (ribonucleic acid) in a sample through reverse transcription polymerase chain reaction (RT-PCR) technology. This method involves converting RNA into complementary DNA (cDNA) using reverse transcriptase, followed by amplification of specific DNA sequences using polymerase chain reaction (PCR). RT-PCR test kits are crucial for identifying viral infections, such as COVID-19, by detecting the presence of viral RNA in patient samples. These kits typically include reagents, enzymes, and primers necessary for the RT-PCR process, ensuring accurate and reliable results for disease diagnosis and monitoring.
Global RT PCR Test Kits Market Analysis Insights Video
Analyst Conclusion
Conclusion
The global RT PCR test kits market will expand significantly by 5.50% CAGR between 2024 and 2031.
Sales of real-time PCR will increase due to its superior accuracy, rapid results, and ability to monitor amplification in real-time, making it essential for precise diagnostics and research applications.
Sales of infectious disease testing will increase due to rising global health threats, the need for rapid and accurate diagnostics, and ongoing public health efforts to manage and prevent disease outbreaks.
Supriya Yadav
Research Analyst at Cognitive Market Research · Cognitive Market Research
Supriya is a Team Lead at Cognitive Market Research & Consulting, leading research initiatives and strategic intelligence projects across the Healthcare, Pharmaceuticals, and Medical Devices & Consumables sectors. With more than two years of experience in market research and data analysis, she plays a key role in helping organizations navigate complex healthcare ecosystems, identify emerging opportunities, and make informed business decisions through data-driven insights and market intelligence.
Combining expertise in both primary and secondary research methodologies with a strong academic foundation in Marketing and Finance, Supriya oversees the execution of market assessments, competitive intelligence studies, forecasting models, stakeholder interviews, trend analysis, and custom consulting engagements. She collaborates with healthcare providers, pharmaceutical manufacturers, medical device companies, industry experts, and other key stakeholders to gather firsthand market perspectives while validating findings through extensive research. Her ability to interpret clinical, commercial, and market data enables clients to better understand industry developments, regulatory influences, innovation trends, and competitive dynamics.
In her leadership role, she manages end-to-end research projects and guides cross-functional teams in delivering high-quality market reports, consulting solutions, and strategic studies. Her expertise in market estimation, forecasting, and analytical modeling helps organizations evaluate market potential, assess growth opportunities, strengthen competitive positioning, and support strategic planning initiatives. By transforming complex healthcare and life sciences data into actionable business intelligence, she enables clients to make confident decisions in rapidly evolving market environments.
Driven by a passion for healthcare innovation and continuous professional development, Supriya remains committed to staying ahead of industry trends, technological advancements, and changing market conditions. Her leadership, analytical mindset, and dedication to research excellence help organizations mitigate risks, capitalize on emerging opportunities, and achieve sustainable growth across the global healthcare and life sciences landscape.
The global market size for RT PCR test kits in 2024 is USD 4126.6 million.
The global RT PCR test kits market is expected to grow with a CAGR of 6.50% over the projected period.
North America held a significant global RT PCR test kits market revenue share in 2024.
Asia-Pacific will witness the fastest growth of the global RT PCR test kits market over the coming years.
The US had the most significant global RT PCR test kits market revenue share in 2024.
The main drivers of the growth of the RT PCR test kits market are high sensitivity and specificity, rising incidence of infectious diseases, and growing awareness of early disease detection.
The infectious disease testing segment had the largest share in the global RT PCR test kits market by application.
★ Reviews
Rate this report
Global RT PCR Test Kits Market Analysis — Table of Contents
Disclaimer: Redacted sample for representative purposes. Charts and data do not depict actual statistics. TOC varies by license selection.
License Edition
Country
Technology
Quantitative PCR, Digital PCR, Standard PCR, Real-time PCR
Application
Infectious Disease Testing, Cancer Testing, Genetic Testing, Others
End User
Diagnostic Laboratories, Hospitals, Research Institutes, Others
17.6 Future Gross Margin Outlook and Profitability Trends
18.1 Key Takeaways
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study.
You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
18.2 Analyst Point of View
18.3 Assumptions and Acronyms
19.1 Primary Data Collection
19.1.1 Steps for Primary Data Collection
19.1.1.1 Identification of KOL
19.1.2 Backward Integration
19.1.3 Forward Integration
19.1.4 How Primary Research Help Us
19.1.5 Modes of Primary Research
19.2 Secondary Research
19.2.1 How Secondary Research Help Us
19.2.2 Sources of Secondary Research
19.3 Data Validation
19.3.1 Data Triangulation
19.3.2 Top Down & Bottom Up Approach
19.3.3 Cross check KOL Responses with Secondary Data
19.4 Data Representation
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Cognitive Market Research employs "The Full Truth™" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Global RT PCR Test Kits Market Analysis Market analysis.
01
Primary Intelligence Gathering
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
02
Secondary Data Triangulation
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
03
Expert Validation Protocol
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
04
Athenaeum AI Processing
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
05
Editorial & QA Review
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
Latest News about RT PCR Test Kits Market
Sources from Medical Devices & Consumables Industry
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Global RT PCR Test Kits Market Analysis market.
Service 01
Market Survey
B2BB2C
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the global rt pcr test kits market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
What's Included
Buyer intent & sentiment analysis
Purchase cycle mapping
Price sensitivity research
Channel preference profiling
Competitive perception study
Most Requested
Service 02
Customized Market Data & Reports
CustomReady Report
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
What's Included
Ready syndicate report (250+ pages)
Custom data scope & segmentation
Excel quantitative models
Board-ready PPT with key findings
Secure cloud portal access
Service 03
Strategic Consultation
With SurveyWith Report
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
What's Included
Dedicated analyst assigned to you
Live walkthrough of findings
Strategic Q&A sessions
Go-to-market recommendations
NDA-protected engagement
Customize This Report
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.
